Investigational Drug Information for HMS5552
✉ Email this page to a colleague
What is the drug development status for HMS5552?
HMS5552 is an investigational drug.
There have been 13 clinical trials for HMS5552.
The most recent clinical trial was a Phase 3 trial, which was initiated on October 15th 2017.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and [disabled in preview]. The leading clinical trial sponsors are Hua Medicine Limited, Tigermed Consulting Co., Ltd, and Covance.
There are two US patents protecting this investigational drug and fifty-two international patents.
Summary for HMS5552
| US Patents | 2 |
| International Patents | 52 |
| US Patent Applications | 27 |
| WIPO Patent Applications | 19 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 3 (2017-10-15) |
| Vendors | 27 |
Recent Clinical Trials for HMS5552
| Title | Sponsor | Phase |
|---|---|---|
| A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers | Hua Medicine Limited | Phase 1 |
| Drug Interaction Study Between Dorzagliatin and Empagliflozin | Hua Medicine Limited | Phase 1 |
| A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers | Hua Medicine Limited | Phase 1 |
Clinical Trial Summary for HMS5552
Top disease conditions for HMS5552
Top clinical trial sponsors for HMS5552
US Patents for HMS5552
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| HMS5552 | ⤷ Try a Trial | Pyrrolidinone glucokinase activators | Hoffmann-La Roche Inc. (Nutley, NJ) | ⤷ Try a Trial |
| HMS5552 | ⤷ Try a Trial | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1H-pyrazol-3-ylamine | HUA MEDICINE (Grand Gayman, KY) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for HMS5552
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| HMS5552 | Argentina | AR071474 | 2028-04-16 | ⤷ Try a Trial |
| HMS5552 | Austria | AT557017 | 2028-04-16 | ⤷ Try a Trial |
| HMS5552 | Australia | AU2009237794 | 2028-04-16 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
